Business Overview Clause Samples

Business Overview. Tudou is a leading Internet video company in China. ▇▇▇▇▇ believes that the "Tudou" brand is one of the most recognized Internet brands in China. The ▇▇▇▇▇.▇▇▇ website was the first UGC and video sharing site launched in China based on the Gartner Report. Tudou provides a robust online platform for Chinese Internet users to upload, watch and share videos via the Internet. By leveraging its recognizable brand and its position as a leading Internet video company in China, ▇▇▇▇▇ has established a large and highly engaged user community. Tudou's registered users increased from approximately 54.4 million as of December 31, 2009 to approximately 78.2 million as of December 31, 2010 and approximately 101.9 million as of December 31, 2011. ▇▇▇▇▇'s average number of new video clips uploaded daily increased from approximately 28,700 in 2009 to approximately 40,000 in 2010 and approximately 57,580 in 2011. In addition, the number of monthly unique visitors to ▇▇▇▇▇.▇▇▇ increased from approximately 137 million in December 2009 to approximately 182 million in December 2010, and to approximately 227 million in December 2011, according to iResearch. In December 2011, the number of monthly video views nearly doubled to 5.2 billion from 2.6 billion in December 2010. Tudou provides an on-demand and interactive viewing experience where its users can find content they want to view, share content they create and connect with other users on its platform. Tudou offers a comprehensive selection of entertaining content including UGC, premium licensed content and content developed in-house. Tudou's extensive content library is designed to meet its users' diverse viewing needs, including entertainment, animation, finance and music. The volume and quality of Tudou's content, combined with its enjoyable user experience, have allowed ▇▇▇▇▇ to establish a large user base, consisting primarily of young, urban, affluent and educated viewers that are particularly attractive to advertisers. Tudou has focused on developing its online platform to provide what ▇▇▇▇▇ believes is the best user experience in the online video industry in China. Tudou has developed a user friendly and interactive interface that ▇▇▇▇▇ believes provides its users with a superior viewing experience. Tudou's website allows its users to watch, upload, rate, comment on and recommend videos, creating an engaging and interactive experience. In addition, Tudou has created rich community features to enhance its users' experi...

Business Overview. Example Sandwich Co. is a new business offering premium sandwiches made with the best local bread, and finest local ingredients. We hope to build up a loyal following by providing only the freshest, most select premium ingredients, all grown locally. We will source all our ingredients from local providers, from corn fed free range chicken and beef hung for a minimum of 21 days, to locally baked ciabatta, baguettes and poppy knots and freshly grown local organic tomatoes and lettuce. We will prepare the ingredients on site, thereby ensuring our customers receive the freshest sandwiches possible. By focussing on particular local farmers, growers and bakers in store, we hope to personalise these local producers to give our sandwich experience a unique feel. We will also feature customers' own sandwich creations for other customers to try and rate. We have forecasted to achieve an annual net profit of £20,518 by the end of Year 1. Year 2 is forecast at £71,160, and Year 3 at £159,775. All from an initial planned investment of £15,000. We have currently invested £5,000, and are now looking for an additional investment of £10,000 to enable the business to start up.

Business Overview. Legion is a company that builds, grows and acquires operating business units in designated high growth industries. Legion was founded on the principles of direct to market capital formation under the new federal JOBS Act legislation recently passed by Congress. The JOBS Act and related rules, including the new crowdfunding rules, allow companies to raise capital through direct investor solicitation using the internet, social media and other direct to market means. We currently own and operate multiple operating subsidiaries, including Legion Funding, LLC, Legion Management Group, LLC, Legion Marketing, LLC and Hilton Institute of Business, LLC. Legion will deploy its vast experience in technology, direct marketing and data management to build one of the most prolific direct funding platforms in the industry, through which it will build and finance portfolio companies utilizing such means as Crowdfunding, Reg A+ (Mini-IPO) offerings and other similar means of accessing growth capital, driving business acceleration and ultimately creating liquidity for Legion and its shareholders.

Business Overview. MicroStrategy® is the world’s first and largest Bitcoin Treasury Company. We are a publicly traded company that has adopted bitcoin as our primary treasury reserve asset. By using proceeds from equity and debt financings, as well as cash flows from our operations, we strategically accumulate bitcoin and advocate for its role as digital capital. Our treasury strategy is designed to provide investors varying degrees of economic exposure to bitcoin by offering a range of securities, including equity and fixed income instruments. In addition, we provide industry-leading AI-powered enterprise analytics software, advancing our vision of Intelligence Everywhere™. We leverage our development capabilities to explore innovation in Bitcoin applications, integrating analytics expertise with our commitment to digital asset growth. We believe our combination of operational excellence, strategic bitcoin reserve, and focus on technological innovation positions us as a leader in both the digital asset and enterprise analytics sectors, offering a unique opportunity for long- term value creation. Our bitcoin strategy generally involves from time to time, subject to market conditions, (i) issuing debt or equity securities or engaging in other capital raising transactions with the objective of using the proceeds to purchase bitcoin and (ii) acquiring bitcoin with our liquid assets that exceed working capital requirements. We intend to fund further bitcoin acquisitions primarily through issuances of class A common stock and a variety of fixed-income instruments, including debt, convertible notes and preferred stock. We view our bitcoin holdings as long-term holdings and expect to continue to accumulate bitcoin. We have not set any specific target for the amount of bitcoin we seek to hold, and we will continue to monitor market conditions in determining whether to engage in additional financings to purchase additional bitcoin. This overall strategy also contemplates that we may (i) periodically sell bitcoin for general corporate purposes or in connection with strategies that generate tax benefits in accordance with applicable law, (ii) enter into additional capital raising transactions that are collateralized by our bitcoin holdings, and (iii) consider pursuing strategies to create income streams or otherwise generate funds using our bitcoin holdings. Additionally, we periodically engage in advocacy and educational activities regarding the continued acceptance and value of Bitco...

Business Overview. We are a commercial-stage biopharmaceutical company applying a precision medicine approach to developing and commercializing life-changing medicines for underserved patient populations suffering from devastating rare diseases and cancer. We have a differentiated portfolio of small molecule targeted oncology assets, including one approved product and several clinical candidates, and are advancing programs in both rare tumor types as well as highly prevalent, genetically defined cancers. OGSIVEO™ (nirogacestat) is our first commercial product. OGSIVEO was approved by the United States Food and Drug Administration, or FDA, on November 27, 2023. OGSIVEO is a novel, oral, selective gamma secretase inhibitor that is the first and only FDA-approved therapy for the treatment of adult patients with progressing desmoid tumors who require systemic treatment. Nirogacestat is also in clinical development as a monotherapy for the treatment of ovarian granulosa cell tumors, or GCT, a subtype of ovarian cancer; we are also evaluating novel combination regimens of nirogacestat alongside B-cell maturation antigen, or BCMA, directed therapies for the treatment of multiple myeloma. Mirdametinib is an investigational oral, small molecule MEK inhibitor that is currently in late-stage development for the treatment of neurofibromatosis type 1-associated plexiform neurofibromas, or NF1-PN. On November 16, 2023, we announced positive topline results from our potentially registrational Phase 2b ReNeu trial of mirdametinib in adult and pediatric patients with NF1-PN. We expect these positive data to support submission of a New Drug Application, or NDA, to the FDA in the first half of 2024 for mirdametinib for the treatment of NF1-PN. Further, we are evaluating mirdametinib for the treatment of solid tumors harboring mitogen activated protein kinase, or MAPK, pathway aberrations in both monotherapy and combination approaches. Brimarafenib is an investigational oral, small molecule, next-generation RAF dimer inhibitor that we are also advancing in the clinic in a distinct set of genetically defined BRAF mutated tumors via MapKure, LLC, an entity jointly owned by us and BeiGene, Ltd. SW-682 is an investigational oral, small molecule TEA Domain, or TEAD, inhibitor that we are evaluating in Hippo-mutant solid tumors. In the first quarter of 2024, the FDA cleared our investigational New Drug Application, or IND, for SW-682 for clinical evaluation, and we anticipate commencing our Phase 1a ...

Business Overview. Propane Margins: Types of Customers:

Business Overview. Atlantic Aviation operates FBOs at 65 airports in the United States. Atlantic Aviation’s FBOs provide fueling and fuel-related services, aircraft parking and hangar services to owners/operators of jet aircraft, primarily in the general aviation sector of the air transportation industry, but also commercial, military, freight and government aviation customers. Summary financial information for Atlantic Aviation is as follows ($ in millions): Revenue. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 683.6 $ 573.4 $ 486.1 EBITDA excluding non-cash items(1) . . . . . . . . . . . . . 126.7 117.5 106.5 Total assets. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,374.4 1,410.1 1,473.2 % of our consolidated revenue. . . . . . . . . . . . . . . . . . 69.1% 68.2% 68.5%

Business Overview. The Company, which will be established within 30 days following the signing of the Agreement at the latest, will operate in the field of this Agreement is as follows; . The operational strategy agreed with The detailed activities of the Company will be included in the Company's articles of association. The founders may, as deemed necessary, modify or expand the business activities by mutual agreement. The Founders may also make changes in accordance with the procedure permitted by the law in force.

Business Overview i3 Mobile shall develop solutions that will enable Client to wirelessly deliver to its customers a wide variety of customizable content, data and transactional services aggregated by i3 Mobile from a variety of third party sources which will include Client's own content (hereafter referred to collectively as "Content Providers").